Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epogen was produced by Amgen.

Amgen may make cuts over anaemia drug reimbursement losses

Epogen and Aranesp were the top-selling biotech-derived drugs in the US in FY06. ... J&J licensed rights to market Epogen to cancer patients under the name Procrit, while Amgen cornered the dialysis market.

Trials and tribulations

The first two EPO products marketed for the treatment of anaemia were epoetin alpha (Epogen / Eprex / Procrit) and epoetin beta (NeoRecormon). ... Epogen was developed through a joint venture between Kirin and Amgen and was the first EPO product launched

Tightly restricted

These are chasing the second best-selling drug in history, the anaemia treatment epoetin alfa - manufactured by Amgen and branded as Epogen and Procrit.

Judge rules in Amgen's favour over Mircera patent row

Amgen said it also believes that Mircera "provides no clinical or patient benefit" over Amgen's own therapies, Epogen (epoetin alfa) and Aranesp (darbepoetin alfa).

Amgen to cut up to 2,600 jobs to save USD 1bn

The cuts were prompted by the loss of Medicare reimbursement for certain cancer treatments for its best-selling anaemia drugs Aranesp and Epogen. ... Both Aranesp and Epogen are responsible for nearly 50 per cent of Amgen's total revenue, which in FY06

[ Previous 5 results ] 1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...